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Aging is one of the most important biological processes and is a known risk factor for many age-
related diseases in human. Studying age-related transcriptomic changes in tissues across the whole 
body can provide valuable information for a holistic understanding of this fundamental process. 
In this work, we catalogue age-related gene expression changes in nine tissues from nearly two 
hundred individuals collected by the Genotype-Tissue Expression (GTEx) project. In general, we find 
the aging gene expression signatures are very tissue specific. However, enrichment for some well-
known aging components such as mitochondria biology is observed in many tissues. Different levels 
of cross-tissue synchronization of age-related gene expression changes are observed, and some 
essential tissues (e.g., heart and lung) show much stronger “co-aging” than other tissues based on a 
principal component analysis. The aging gene signatures and complex disease genes show a complex 
overlapping pattern and only in some cases, we see that they are significantly overlapped in the 
tissues affected by the corresponding diseases. In summary, our analyses provide novel insights to 
the co-regulation of age-related gene expression in multiple tissues; it also presents a tissue-specific 
view of the link between aging and age-related diseases.
Aging is a certainty in our largely uncertain lives. It is a process in which multiple organs and tissues 
gradually lose physiological integrity, followed by functional impairment and eventually death of the 
individual1. The molecular mechanisms underlying aging are not fully understood, despite the enormous 
amount of findings and theories that have emerged in the past decades. The current hypotheses encom-
pass genetic predisposition, calorie restriction, mitochondrial dysfunction, telomere attrition, genomic 
instability, and many others2–6. As there is also no unanimous agreement on fundamental issues such as 
whether aging is genetically programmed7,8, the ultimate cause of aging and the interconnections among 
various aging mechanisms remain to be established. On the contrary is the fact that aging is a major risk 
factor for many complex diseases such as cardiovascular disease, cancer, Type 2 diabetes, Alzheimer’s 
disease, and Parkinson’s disease9–13. Given the rapidly expanding aging population world-wide14, aging 
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research is increasingly important as it holds the promise for unravelling the secrets of longevity and for 
bringing new solutions to the treatment of age-related diseases.
With the advent of various high throughput technologies, it is now feasible to measure an individ-
ual’s panomics (including transcriptome, metabolome, epigenome, etc.) at a reasonable cost15. The rich 
information in panomic data brings enormous opportunities to the aging research field. For example, 
using methylation data, Horvath et al. defined a molecular clock composed of 353 CpG sites that could 
accurately predict the human age16. By examining the transcriptome changes in the aging neocortex and 
cerebellum in mice, Lee et al. observed genes associated with inflammatory responses, oxidative stress, 
and reduced neurotrophic support in both brain regions17. The AGEMAP project which profiled gene 
expression in 16 tissues in mice also identified age-associated genes and revealed tissue specific aging 
patterns18. By comparing the transcriptional profiles in mice to those of other species (human, flies, and 
worms), genes involved in the electron transport chain showed common age regulation in all four spe-
cies. A large number of human tissue age-gene expression association studies have been performed in 
various tissues (e.g., brain, muscle, blood, and kidney)19–25. However, the previous gene expression based 
studies only examined a rather limited number of tissue types. Due to difference in sample collections, 
platforms used for profiling, and data processing procedures, it is difficult to compare and combine the 
findings from these studies. The GTEx project provides RNA-Seq based transcriptome profiles in more 
than 40 tissues from hundreds of human donors of various ages, making it one of the largest single data 
sets with the most comprehensive tissue types for studying the genetics of human tissue gene expression 
and age-associated gene expression26. Particularly, since multiple tissues are collected from the same indi-
viduals, cross-tissue analysis of age-associated gene expression changes becomes feasible. For simplicity 
we subsequently refer to such genes as “aging genes”.
In this work, we first identify aging gene signatures in nine GTEx tissues and explore their functional 
characteristics. We then study the synchronization of age-related gene expression changes across differ-
ent tissues. We also study the connections between tissue aging and complex diseases. In addition, we 
examine the aging gene signatures across different species, and compare our results with other related 
aging studies.
Results
Identification of tissue specific age-associated genes in the GTEx data. The GTEx project (v3, 
accessed in December 2012) provided 1,641 whole transcriptome profiles in more than 40 tissues from 
nearly two hundred post-mortem human donors26. Nine tissues had sample sizes of greater than 80, 
namely, the subcutaneous adipose, tibial artery, left ventricle heart, lung, skeletal muscle, tibial nerve, 
skin, thyroid, and whole blood. We considered these nine tissues in our study and omitted other tissue 
types which had fewer samples. The sample age and gender distributions were plotted in Fig. 1, in which 
the age distributions of all samples, female samples, and male samples were shown in the left, middle, 
and right columns, respectively and each row corresponds to a tissue type. Overall, donors’ chronological 
ages ranged from 20 to 70. A customized regression model combined with bootstrapping was used to 
define age-gene expression associations (see Methods).
Briefly, we followed the GTEx consortium’s practice of pre-processing the gene expression data with a 
slight modification26. We corrected gender, the top three genotype principal components (PCs) to reduce 
the impact of population structure, and a few top gene expression PCs that did not significantly correlate 
with age (p-value > 0.05). Correcting gene expression PCs allows us to remove potential confounding 
factors such as the batch effect27. Multiple alternative models of correcting expression PCs were consid-
ered and compared (see details in Methods). Since low expressed genes are usually more vulnerable to 
measurement errors28, we removed 20% low expressed aging genes. We bootstrapped the samples for 100 
times and compiled our final aging gene list by including genes whose expression levels were significantly 
associated with age in at least 50 runs. The readers are referred to Methods for the details.
We summarized the numbers of age-associated genes in all nine tissues in Table 1 and the detailed 
information for all the 41,298 genes was provided in Supplementary Data S1. As shown in Table  1, 
the number of age-associated genes in the nine tissues ranged from 3 to 3,287. The largest number 
(n = 3,287) was observed in whole blood; while only 12 and 3 age-associated genes were identified in 
skin and thyroid, respectively. The large difference in the number of age-associated genes observed in the 
GTEx data is consistent with previous observations in mouse18 and human22. To estimate the number 
of false positives that could be contained in our aging genes, we permuted sample ages for 1,000 times 
and repeated the aging gene identification procedure on the permutated data (see Methods). The results 
were summarized in the column named “Permutation” in Table 1. As shown in Table 1, the frequencies 
of identifying equal or more age-associated genes in the permuted datasets are very small (no greater 
than 5 times except for skin and thyroid), and the numbers of false positives are small compared to the 
number of findings in the real data in most tissues (skin and thyroid are the two exceptions), indicating 
that majority of the identified gene-age associations in the seven tissues are not due to random chance.
Because of the small number of age-associated genes and high false positive rates in the skin and 
thyroid tissues, we excluded them and only performed further analysis on seven tissues. To visualize the 
expression pattern of the inferred aging genes, a heatmap was generated for each tissue (Supplementary 
Fig. S1). As shown in Fig. 2a, for the adipose tissue, the samples were clearly clustered into two groups 
based on the Euclidian distance with “Ward” measurement29. The left-side group contained many 
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Figure 1. Age distribution of donors in nine tissues. The histograms of donor age distribution for all 
samples, females only, and males only.
Tissues Sample Size
Aging genea Permutationb
Up Down Overall Frequency Number
Adipose 94 652 482 1134 0 2.16
Artery 112 2258 824 3082 0 5.11
Heart 83 374 454 828 0 2.43
Lung 119 329 547 876 0 2.95
Muscle 138 766 121 887 0 1.53
Nerve 88 116 67 183 0 1.47
Skin 96 6 6 12 36 7.40
Thyroid 105 2 1 3 10 0.34
Blood 156 1381 1906 3287 5 82.60
Table 1.  Number of age-associated genes in 9 human tissues and permutation test. aNumber of 
significant genes after adjusting for 3 types of confounding factors: (1) gender, (2) the top three genotype 
PCs, and (3) among the top 5 gene expression PCs, the PCs not significantly (p-value > 0.05) correlated with 
age, and removing 20% low expressed genes in the original expression data. Columns “Up”, “Down”, and 
“Overall” list the number of up-regulated, down-regulated, and overall aging genes, respectively. bResults of 
aging genes from 1,000 permutation tests. The column “Frequency” lists the frequencies of identifying equal 
or more significant genes in 1,000 permuted datasets than those in the original one. The column “Number” 
lists the average number of aging genes in 1,000 permutation runs.
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younger individuals compared to the right-side group. The apparent separation of “young” and “old” 
group was observed in all seven tissues and it is of note that the groupings were different in different 
tissues (Supplementary Fig. S1). A student’s t-test on the age groups, “young” and “old”, generated sig-
nificant results (p-values less than 3.59 × 10−3) in all seven tissues (Supplementary Table S1). The age 
distributions of “young” and “old” samples in the seven tissues were provided in Supplementary Fig. S2.
In addition to the grouping on the age axis, the aging genes were also grouped into up-regulated 
and down-regulated genes, which correspond to positive and negative signs of the coefficient of “age” 
term in the regression model. In four out of the seven tissues, we saw more up-regulated aging genes 
than down-regulated ones (heart, lung, and blood are exceptions) (Table  1). To visualize the age-gene 
expression association at single gene level, we selected two genes with either strong positive or nega-
tive age-association (PYH1N1 and EIF5AL1) in adipose tissue and showed the scatter plots in Fig. 2b. 
The Pearson correlation coefficients of these two genes are 0.63 (p-value = 7.43 × 10−12) and − 0.57 
(p-value = 2.89 × 10−9), respectively. As can be seen in Fig.  2b, the age-gene expression association is 
evident for these two genes and there is no apparent difference between male (blue) and female (red). 
The scatter plots of the top 100 age-associated genes in all seven tissues are provided in Supplementary 
Data S2.
Figure 2. Age-associated gene expression in subcutaneous adipose tissue. (a) Heatmap of 1,134 age-
associated genes (row) on 94 samples (column). Colors represent normalized gene expression values with 
blue for low expression and red for high expression. The age of each individual is displayed at the bottom 
and also illustrated in color bar at the top with dark green for young and yellow for old. (b) Scatter plot of 
2 representative age-associated gene expression patterns PYH1N1 and EIF5AL1 in adipose tissue. Pearson-R 
value in the title represents the Pearson correlation coefficient between gene expression and age across all 
samples. The solid blue triangles plot male samples and solid red circle female samples. Similarly, the blue 
and red lines denote the regression lines for male and female samples, respectively.
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Functional annotation of aging genes points to a large collection of biological processes. To 
obtain a functional overview, we annotated the up- and down-regulated aging genes separately, using 
David tools30. Due to space limitation, we showed a subset of the top representative annotations in 
Table 2, and provided a complete list in Supplementary Data S3. The aging gene signatures are signifi-
cantly enriched for a wide spectrum of Gene Ontology (GO) terms and pathways. The most frequently 
appeared category is mitochondrion. In five out of seven tissues (adipose, artery, heart, lung, and blood), 
the enrichment was all seen in the down-regulated aging genes. This result supports the central role 
of mitochondria in human aging. Mitochondria dysfunction in aging has been observed in multiple 
model organisms and is among the most recognized aging theories1,31–33. For example, a systemic RNA 
interference (RNAi) screen for gene inactivation that increases lifespan in worms showed a 10-fold over-
representation of genes encoding mitochondrial proteins34. Many other functions known to associate 
with aging were also observed, e.g., down-regulation of electron transport chain (in adipose and heart) 
and up-regulation of cell death and inflammation response (both in artery). It is of note that several 
Tissue
Up-regulated gene set Down-regulated gene set
IDa Description Adj p-valb ID Description Adj p-val
Adipose
GO:0005578 proteinaceous extracellular matrix 1.52 × 10−3 GO:0005739 mitochondrion 5.77 × 10−47
GO:0005815 microtubule organizing center 2.05 × 10−2 hsa05016 Huntington’s disease 5.12 × 10−8
GO:0043167 ion binding 3.85 × 10−2 hsa05012 Parkinson’s disease 9.22 × 10−8
GO:0022900 electron transport chain 2.68 × 10−6
GO:0006631 fatty acid metabolic process 2.72 × 10−6
hsa05010 Alzheimer’s disease 2.03 × 10−5
Artery
GO:0060589 nucleoside-triphosphatase regulator activity 3.34 × 10−10 GO:0030163 protein catabolic process 5.96 × 10−14
GO:0030695 GTPase regulator activity 5.00 × 10−10 GO:0005739 mitochondrion 1.27 × 10−6
GO:0006952 defense response 6.26 × 10−8 GO:0019787 small conjugating protein ligase activity 2.20 × 10
−5
GO:0006954 inflammatory response 2.35 × 10−4 GO:0000278 mitotic cell cycle 1.57 × 10−3
GO:0008219 cell death 1.38 × 10−3 hsa05016 Huntington’s disease 1.25 × 10−2
Heart
GO:0005739 mitochondrion 1.29 × 10−36
GO:0006099 tricarboxylic acid cycle 3.20 × 10−10
hsa05012 Parkinson’s disease 8.79 × 10−8
hsa05016 Huntington’s disease 7.10 × 10−7
GO:0022900 electron transport chain 5.46 × 10−5
GO:0006511 ubiquitin-dependent protein catabolic process 2.81 × 10
−4
Lung
GO:0005739 mitochondrion 9.57 × 10−5
GO:0005764 lysosome 1.00 × 10−3
GO:0005773 vacuole 1.29 × 10−3
Muscle
GO:0016071 mRNA metabolic process 1.83 × 10−4 GO:0000786 nucleosome 3.23 × 10−2
GO:0006281 DNA repair 3.87 × 10−3
GO:0046930 pore complex 7.85 × 10−3
Nerve
GO:0048812 neuron projection morphogenesis 1.30 × 10−2
GO:0048666 neuron development 1.47 × 10−2
GO:0007155 cell adhesion 4.99 × 10−2
Blood
GO:0006986 response to unfolded protein 1.88 × 10−4 GO:0015031 protein transport 1.10 × 10−11
GO:0007049 cell cycle 8.76 × 10−4 GO:0016192 vesicle-mediated transport 1.64 × 10−8
GO:0005524 ATP binding 6.13 × 10−3 GO:0007264 small GTPase mediated signal transduction 2.41 × 10
−4
hsa04722 Neurotrophin signaling pathway 1.71 × 10−3
GO:0006915 apoptosis 9.28 × 10−3
hsa05010 Alzheimer’s disease 1.88 × 10−2
GO:0005739 mitochondrion 4.71 × 10−2
Table 2.  Function enrichment of up- and down-regulated age-associated genes in 7 tissues.  
aTop representative gene set categories. bAdj. p-val denotes the Benjamini false discovery rate.
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disease pathways, e.g., “hsa05016: Huntington’s disease”, “hsa05012: Parkinson’s disease”, and “hsa05010: 
Alzheimer’s disease” are significantly enriched in aging gene signatures in multiple tissues, and these 
neurodegenerative diseases are also known to be age-dependent12,13,35.
Besides the well-known age-related functions, we also saw multiple processes that are less known for 
their involvement in aging. For example, we observed the up-regulation of cell adhesion in nerve, and 
up-regulation of ion binding in adipose. All these significantly over-represented biological functions 
suggest that human aging is an extremely broad and complex process, with both common and specific, 
up- and down-regulated collections of biological activities in various tissues.
Synchronization of multi-tissue age-related gene expression changes in human. As shown 
in Fig.  2a and Supplementary Fig. S1, although the chronological ages of the tissue donors are largely 
consistent with the “young” or “old” clustering, there are some apparent “outliers”. For example, the 15th 
adipose sample (from the left) in Fig. 2a is from an individual with an old chronological age of 70, but is 
clustered with the “young” group where most donors range in age from 20 to 50. This indicated that the 
molecular age of adipose tissue from this individual is about 30 years younger than its chronological age. 
Sample mislabelling can be excluded as a possible cause for such “outliers”, due to the accurate sample 
matching using variants called from RNA-Seq data and DNA genotype data. In fact, this finding is con-
sistent with previous observations in the mouse data from the AGEMAP project18. Although AGEMAP 
concluded that different tissues in the same mouse tend to have coordinated aging, they also observed 
“outliers” or mouse tissues that clustered into different aging patterns. They hypothesized that individual 
mice could be composed of a mosaic of tissues with different physiological ages.
One question we asked is whether age-related expression changes in different tissues are coordinated. 
It is of note that our study design is not longitudinal, therefore we are unable to study the coordinated 
aging gene expression changes among tissues in single individuals. Instead, we studied this at the popu-
lation level with the assumption that common patterns of age-related expression changes exist in human 
population and can be observed in our samples. To answer the aforementioned question, we estimated 
tissues’ apparent ages or their relative ages (ranks) in the population, and then we calculated their covari-
ation in the population for each tissue-pair. Specifically, we considered two methods: (1) an unsupervised 
method based on principal component analysis (PCA) and (2) a supervised learning method using the 
Elastic Net regression36.
PCA analysis. Briefly, we calculated the PCs of aging gene expression in each tissue. In all seven 
tissues, the first PC (PC1) captured the dominant variance of the aging gene expression and sample 
coordinate on PC1 was highly correlated with the sample’s chronological age with a mean Spearman 
correlation coefficient of 0.55 (Supplementary Fig. S3). Therefore we only considered PC1 to estimate 
the relative rank of tissue’s apparent age.
As we performed such calculation in each tissue separately, different tissues from the same individual 
may have different age ranks among donors. We then calculated the Spearman correlation coefficient 
of two tissues’ apparent ages across all the individuals, named as “co-aging coefficient”. A high co-aging 
coefficient indicates that the tissue pair has tight synchronized age-related expression changes in the pop-
ulation, so that if we randomly select an individual and profile the tissue pair, when one tissue appears to 
be young, the other tissue has a high chance of being young too, or vice versa. We plotted all pair-wise 
tissue correlations in Fig. 3a. As shown in Fig. 3a, high correlations were seen among lung, blood, and 
heart (e.g., the correlation between lung and blood was 0.73), whereas much less correlations were 
observed among other tissues (e.g., the correlation between muscle and blood was only 0.27) (Fig. 3b,c).
One potential cause for observing the synchronization among tissue specific age-related gene expres-
sion changes is cross-tissue contamination, in which case gene expression profiled from one tissue is a 
mixture of gene expression from multiple tissues (e.g., heart tissues might be contaminated with blood). 
To evaluate the level of contamination, we performed a clustering of samples based on gene expression 
using (1) all genes and (2) all aging genes. We observed that the samples collected from the same tissue 
were grouped tightly together in either case (see Supplementary Fig. S4a and S4b). This indicated that 
cross-tissue contamination may not be the main cause for the strong correlation of age-related gene 
expression changes amongst certain tissues.
The tight co-aging amongst the lung, heart, and blood tissues is better visualized in Fig. 3d, in which 
we mapped each overlapping sample (across the three tissues) into a ball in 3 dimensional space accord-
ing to its rank (based on the coordinate of PC1 projection) in each tissue. It is clear that most samples 
showed synchronized aging in these three tissues (ball points in grey color), as they are aligned with 
the diagonal line connecting (0, 0, 0) and (60, 60, 60) and positioned closely to their chronological 
ages. A couple of outliers are also seen, as they are far off the diagonal line indicating large deviation 
from donors’ chronological ages. We labelled samples with deviation p-values less than 0.05 as outliers 
and colored them in red (see Methods for details). We also observed that deviation has a positive cor-
relation with chronological age (see Supplementary Table S2), as we saw greater age deviations in old 
individuals than those in young individuals. This is particularly true for tissue pairs with relatively weak 
synchronization. For example, for the artery and nerve tissues (Fig.  3e), the deviation of sample age 
rank increases significantly as age increases (p-value = 2.04 × 10−4); but for the lung and blood tissues 
(Fig. 3f), although the correlation remains positive, it is not significant (p-value = 0.18).
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Predicted age using Elastic Net. As an alternative approach to PCA, we predicted tissue age using 
Elastic Net (EN) and performed tissue co-aging analysis using the predicted ages. Briefly, we randomly 
divided samples into 10 subgroups of equal size and predicted sample age in each subgroup using data 
from the other 9 subgroups. To reduce bias due to random sampling, we repeated the process for 100 times 
and the mean of the predicted age in these runs was used as sample’s predicted age (see Supplementary 
Methods for details). The tissue co-aging patterns based on EN were plotted in Supplementary Fig. S5. 
As can be seen, the pattern is different from the one obtained by PCA method. Using EN, the most 
correlated tissue pair is nerve and artery (Spearman correlation coefficient of 0.76), while in the PCA 
analysis, apparent ages of heart, lung, and blood are highly correlated. As a supervised learning method, 
Elastic Net is designed to minimize the difference between the predicted age and chronological age in 
the training samples. As a consequence, we observed that the Spearman correlation between Elastic Net 
predicted age and chronological age was consistently higher than that in the PCA results for all tissues 
(Supplementary Table S3). The apparent “outliers” seen in the PCA analysis were predicted to be less 
dramatic by the EN. For example, the 70 years old adipose tissue was ranked at 13th position in all the 
94 samples based on its PC1 projection (smaller rank corresponds to younger age), while based on EN, 
it was ranked more to the donor’s chronological age (36th position). In Supplementary Fig. S5, we also 
listed the rooted mean square error (RMSE) of EN prediction for each tissue. With current small sample 
size, EN showed large errors, e.g., artery and nerve showed RMSEs of 6.75 and 7.20 respectively, while 
blood tissue showed the largest RMSE of 11.94.
Despite the difference in co-aging patterns observed in PCA and EN analyses, both methods showed 
that the aging of artery and nerve is strongly correlated with chronological age and this correlation is 
Figure 3. Aging synchronization in multiple tissues. (a) Heatmap of tissue co-aging in adipose, artery, 
heat, lung, muscle, nerve, and blood tissues. The number in each square in the lower triangle indicates the 
co-aging coefficient between a tissue pair; and the sample number for each tissue is also presented in the 
top of the sample column. (b) Scatter plot of age rank correlation for two highly correlated tissues lung and 
blood and the regression line. Spearman-R value represents the Spearman correlation coefficient between the 
ranks defined by the two tissues across all samples. (c) Scatter plot of age rank correlation for two relatively 
uncorrelated tissues muscle and blood and the regression line. (d) Scatter plot of age rank correlation for 
heart, lung, and blood; the axis ranges from 0 to 60 indicating the rank of each sample (in total 59 donors 
with data in all these 3 tissues); the chronological ages are marked for some representative samples and 
the outliers are highlighted in red. (e) Correlation between age rank deviation and age in artery and nerve. 
The shaded area indicates the confidence interval of the regression line. “p-value” indicates the p-value for 
regression coefficient being deviated from 0. (f) Correlation between rank deviation and age in lung and 
blood.
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much smaller for blood, suggesting different tissues may have different levels of deviation from the indi-
vidual’s chronological age (Supplementary Table S3).
Tissue specific link between aging genes and complex disease genes. Aging is a known risk 
factor for many diseases, such as cardiovascular disease, cancer, arthritis, Alzheimer’s disease, Parkinson’s 
disease, and Type 2 diabetes37–39. The functional enrichment in the previous section indicated that aging 
gene signatures have clear connections with some age-related diseases like Alzheimer’s disease. To com-
prehensively evaluate the tissue specific connections between aging and diseases, we compiled a large 
disease gene list containing 234 disease/trait categories by merging two datasets, the NIH GWAS40 and 
OMIM41 catalog (see Methods for details).
Using this gene set, we determined the enrichment of the disease genes in tissue specific aging gene 
signatures considering the up- and down-regulated gene signatures separately. A large number of diseases 
showed tissue specific connections with aging genes. To visualize the result, we selected the top 10 diseases/
traits that showed the most significant enrichment for aging genes in each tissue. By considering the unique 
diseases/traits in all seven tissues, we obtained 55 diseases that showed significant over-representation in 
up-regulated aging genes, and 53 diseases that showed significant over-representation in down-regulated 
aging genes. The results for up-regulated aging genes and down-regulated aging genes were shown in 
Fig. 4a,b, respectively, and the full enrichment analysis results were provided in Supplementary Data S4. 
As shown in Fig. 4, in some cases, the over-representation of disease genes in tissue specific aging gene 
signatures was observed in the tissue types that are commonly considered as the disease affected tissue. 
For example, the down-regulated aging gene signature in the lung shows most significant enrichment in 
genes associated with chronic obstructive pulmonary disease (COPD)-related biomarkers and pulmo-
nary function, with p-values of 2.51 × 10−5 and 3.40 × 10−5, respectively. The total cholesterol associated 
genes and obesity-related traits are significantly over-represented in the adipose tissue down-regulated 
aging genes with p-values of 8.32 × 10−3 and 2.84 × 10−2, respectively. It is of note that some of these 
p-values may not survive the multiple testing correction, and could represent false positive results. In 
addition, a large number of immune-mediated inflammatory disease genes are over-represented in the 
blood and artery aging gene signatures, including Crohn’s disease, inflammatory bowel disease, multi-
ple sclerosis, rheumatoid arthritis, and ulcerative colitis. Chronic low-grade systemic inflammation is a 
common manifestation of aging42,43, and our results further support the strong connection between aging 
and inflammatory diseases in the human population. On the other hand, some enrichment results are 
less intuitive, for example, disease genes of age-related macular degeneration (AMD), a disease of the 
eye, appeared to be over-represented in the up-regulated aging genes of the lung (Fig. 4a). Overall our 
results suggest that the connections between aging and diseases are very complex. Although we observed 
some direct connections between disease and tissue type, many connections could be indirect and thus 
undetectable from simple enrichment analysis. Aging and complex diseases could also be fundamentally 
different, as some individuals can have a long period of disease free aging life.
Aging genes in mouse are different from human aging genes from GTEx. Mouse models have 
been widely used to study human diseases. Although multiple studies have employed various mouse 
models to study aging18,44, it is not clear whether at the molecular level, mouse aging is comparable to 
human aging. To address this question, we compared the human aging genes derived from the GTEx 
data with mouse aging genes obtained from the AGEMAP project18. The AGEMAP project identified 
mouse age-associated genes in nine tissues: adrenals, cerebellum, eye, gonads, heart, lung, spleen, spinal 
cord, and thymus, among which two tissues (i.e., heart and lung) were also profiled by GTEx.
To do a cross species comparison, we first obtained the homologous mapping from homologene 
database in NCBI (released in 12/14/2012) (ftp://ftp.ncbi.nih.gov/pub/HomoloGene/). Based on this 
mapping, 6,454 and 6,576 homologous (human/mouse) gene pairs were identified in the heart and lung 
data, respectively from both GTEx and AGEMAP (Supplementary Data S5). Among the 6,454 homolo-
gous genes, there are 346 aging genes (p-value < 0.001, similar to18) in the human heart (Supplementary 
Data S5) and 18 aging genes in the mouse heart18. Similarly, there are 324 aging genes in the human 
lung (Supplementary Data S5) and 66 aging genes in the mouse lung18. There is only one common 
age-associated gene DAZAP1 in both human and mouse heart tissue (p-value = 0.63, one-tail Fisher’s 
exact test). DAZAP1 (DAZ Associated Protein 1) is required for normal growth and spermatogenesis 
in mice45,46 and is deleted in many azoospermic and severely ligospermic men47. A recent study showed 
that DAZAP1 regulates the splicing of Crem, Crisp2, and Pot1a transcripts48. Similarly, there are only 
three common age-associated genes PTPN6, CDKN1C, and CLIP1 (mapped to Hcph, Cdkn1c, and Rsn 
in mouse) in lung tissue, the p-value for the one-tail Fisher’s exact test is 0.64.
Overall, our results suggest a very large difference in aging genes between the human and mouse, a 
finding consistent with results from previous studies18,49. The large difference in the aging gene pattern 
has also been observed in other animals like chimpanzee50, suggesting the aging process is indeed less 
well conserved across species as compared to some other biological processes51. It is of note that the study 
designs including sample size, gender distribution, age distribution, and experiment conditions are quite 
different between the AGEMAP and GTEx studies. This might contribute in part to the observed large 
difference and further investigation is required to ensure that the dissimilarity of the two species is not 
due to design artefacts.
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Comparison with other human age-focused gene expression studies. Glass et al. performed 
an analysis on the Multiple Tissue Human Expression Resource (MuTHER) data to identify aging genes 
in skin, blood, brain, and adipose tissues22. Three tissues are related to GTEx tissues, namely, adipose 
(subcutaneous fat), skin, and lymphoblastoid cell lines (LCLs) from blood.
We applied our model to the MuTHER dataset, and compared the identified aging genes with those 
from GTEx. As shown in Supplementary Table S4, 157 common aging genes were identified in adipose 
tissue (enrichment p-value = 1.51 × 10−4). In contrast, only 4 common aging genes were identified in 
skin and blood tissues, respectively (enrichment p-values were both 0.17). The common aging genes 
were listed in Supplementary Data S6.
We also compared aging genes we derived from the MuTHER dataset using our method with 
those reported by GLASS et al.22. They showed a significant overlap with p-values of 1.39 × 10−177, ≈ 0 
(< 4.9 × 10−324), and 2.06 × 10−7 respectively in adipose, skin, and blood (see Supplementary Data S7). 
This implies that the large difference of aging genes in the skin and blood between MuTHER and GTEx 
data is inherent to the data themselves, rather than driven by the difference in the analytic methods. It 
is of note that in MuTHER project, peripheral blood samples were collected, and LCLs were generated 
through EBV-mediated transformation of the B-lymphocyte component, while in GTEx, the whole blood 
tissues were used for gene expression profiling. Therefore, it is likely that the difference in aging genes 
from LCLs vs GTEx whole blood is at least partially due to the sample difference. In addition, the skin 
tissues were collected from different parts of the body in GTEx (sun exposed lower leg) and MuTHER 
Figure 4. Correlation between age and common diseases in multiple tissues. (a) Overlap enrichment 
between up-regulated aging genes and disease genes in GTEx tissues and (b) Overlap enrichment between 
down-regulated aging genes and disease genes in GTEx tissues. The color depth indicates the normalized 
negative logarithm of the p-value of the Fisher’s exact test for overlapping between disease and aging genes 
in specific tissue.
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(relatively photo-protected infra-umbilical skin). It indicates that even the same tissue may have differ-
ent aging patterns given a different environment such as sun light exposure. Other factors, such as the 
different gene expression platforms may also contribute to the gross differences in aging genes observed 
in the different human studies.
Discussion
In the present study, we present a holistic view of human aging in multiple tissues by analysing the GTEx 
data. From GO and pathway enrichment analyses, mitochondrion biology is highlighted as the most 
commonly regulated biological process associated with age. We also observed many other biological 
processes associated with age such as DNA repair, electron transport chain, and apoptosis. With exten-
sive involvement of a large number of biological processes during aging, an important task is to identify 
the connections amongst these aging components and reveal the causal relationship among them and 
identify the key driver genes as candidates for anti-aging drug development.
Through tissue co-aging analysis, we show that tissue aging as reflected by the age-related gene expres-
sion changes is potentially synchronized at different levels. In PCA analysis, vital tissues like lung, heart, 
and whole blood showed tighter co-aging pattern compared to other tissues like muscle. The different 
levels of tissue age-related expression change synchronization may reflect the different selection pressures 
on the functional connections among tissues in the early developmental stage which extends into the 
late stage of our lifespan.
The high correlation between blood and heart/lung provides a hint that circulation system could play 
a role in synchronizing tissue functions with respect to aging. Recent studies have shown that blood from 
young mice and possibly GDF11, a circulating transforming growth factor–β (TGF-β ) family member 
can reverse cardiac hypertrophy52, stimulate brain vascular remodelling and increase neurogenesis in 
aging mice53.
It is of note that the co-aging pattern derived from PCA and Elastic Net are different. This difference 
may be caused by the limited sample size that is currently available for EN prediction. A more robust 
evaluation is possible when GTEx project completes with more than 900 individuals being profiled.
Our study identifies some apparent connections between aging and complex diseases. However, there 
are a large number of connections between tissue specific aging and diseases that are much less obvious 
and some are hard to interpret. Clearly, a more detailed study is required to fully understand the mech-
anistic details of all the connections between aging and diseases.
Methods
GTEx data. GTEx data (v3, December 2012 release) provides expression levels of 41,298 genes in nine 
human tissues: subcutaneous adipose, tibial artery, left ventricle heart, lung, skeletal muscle, tibial nerve, 
skin (from sun exposed lower leg), thyroid, and whole blood. The sample size of each tissue ranges from 
83 to 156 (see Table 1). Since GTEx consortium paper26 provides full information on sample collection, 
RNA collection, RNA-Seq experiment, gene expression estimation, quality control, and gene expression 
normalization, we did not reproduce such information here.
Linear regression model for aging gene detection. In each tissue, we modelled gene expression 
using the following linear regression model:
∑ ∑β γ δ µ α ε= + + + + +
( )= =
Y Age Sex Genotype PC








where, Yij is the expression level of gene j in sample i, Agei denotes the age of sample i, Sexi denotes the 
sex of sample i, Genotypeik(1 ≤ k ≤ 3) denotes the value of the k-th principal component value of geno-
type profile for the i-th sample, PCik(1 ≤ k ≤ N) denotes the value of the k-th principal component value 
of gene expression profile for the i-th sample, N is the total number of top PCs under consideration, 
εij is the error term, βj is the regression intercept (for gene j), γj is the age regression coefficient, δj is 
the sex regression coefficient, μjk(1 ≤ k ≤ 3) is the regression coefficient for the k-th genotype PC, and 
αjk(1 ≤ k ≤ N) is the regression coefficient for the k-th gene expression PC. For each gene j, a least square 
approach was used to estimate the regression coefficients. If γj was significantly deviated from 0, gene 
j was considered to be age-associated. Gene j was up-regulated with age if γj > 0 and down-regulated 
if γj < 0. We performed the false discovery rate (FDR) adjustment on the p-values using Benjamini 
Hochberg method54 and an FDR less than 0.05 was used as the significance threshold throughout the 
paper unless otherwise specified.
In addition, we also removed 20% low expressed aging genes. Specifically, for each aging gene, we 
ranked samples based their expression levels in descending order and calculated the mean expression 
levels in the top 25% samples. We then ranked all the aging genes according to this mean expression 
value in descending order and removed the bottom 20% aging genes.
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Correcting for confounding factors based on principal component analysis. Correcting con-
founding factors is usually indispensable in revealing the true relationship between gene expression 
change and aging. Besides sex, major principal components (PCs) of genotype and gene expression 
profile in sample space are also frequently used as confounding factors in gene expression analysis to 
boost true signal detection. For example, removal of the top PCs has led to a significant increase in the 
number of expression quantitative trait loci (eQTLs) identified55,56. To remove potential confounding 
factors such as the batch effect, we adopted an approach similar to Pickrell et al.27. It is of note that we 
only considered top 3 genotype PCs (similar to GTEx eQTL study26) and top 5 gene expression PCs 
throughout this study.
Since age could be one of the top gene expression PCs or correlate with them, directly correcting 
these PCs is not suitable for our study. Thus, we tested nine models (namely, M1–M9) to correct possible 
confounding factors: (1) M1: no correction of any confounding factors; (2) M2: correcting gender and 
the top 3 genotype PCs; (3) M3-M7: correcting gender, top 3 genotype PCs, and the gene expression PCs 
correlated with age with the Pearson correlation coefficient less than a threshold of 0.1, 0.2, 0.3, 0.4, and 
0.5, respectively; (4) M8: correcting gender, the top 3 genotypes, and the combination of gene expression 
PCs that delivered the largest number of age-associated genes; and (5) M9: correcting gender, the top 
3 genotype PCs, and gene expression PCs that do not significantly (p-value > 0.05) correlate with age. 
The Pearson correlation between the top 5 gene expression PCs and age was listed in Supplementary 
Table S5 and the number of aging gene identified after removing 20% low expressed genes was listed 
in Supplementary Table S6. It can be seen that the chronological age was significantly correlated with 
top PCs in a few tissues (e.g., PC1 in adipose, artery, heart, lung, and blood) (Supplementary Table S5). 
In addition, confounding factors correction had some influence on the number of inferred aging genes 
especially for heart, lung, and blood (Supplementary Table S6).
To help us evaluate these models, we performed an enrichment analysis with GenAge genes57 using 
20,059 GTEx protein coding genes as background (Supplementary Data S8). GenAge provides a man-
ually curated list of 298 genes that presumably regulate the human aging process (accessed on Feb 
20th, 2015). The enrichment analysis results of the nine models were shown in Supplementary Table 
S7, in which we also demonstrated the effect of removing 20% low expressed age-associated genes. In 
all models, age-associated genes were more significantly overlapped with GenAge genes after remov-
ing low expressed genes, suggesting that this filtering may help to refine the true age-associated genes. 
The model generating the most significant p-value is M9, by which we inferred a total of 7,925 unique 
protein-coding age-associated genes from all nine GTEx tissues. The number of overlap genes between 
these aging genes and GenAge genes is 173 with a p-value of 2.69 × 10−11 (Supplementary Table S7).
Bootstrapping, permutation analysis, and the effect of sample size. To further ensure our 
age-associated genes are not sensitive to a particular input sample set, we bootstrapped the samples (with 
replacement) for 100 times. In each run, we identified age-associated genes from the bootstrapped sam-
ples using M9. A gene is in the final age-associated gene list if: (1) it is an age-associated gene in more 
than 50 bootstrap runs and (2) it is an age-associated gene using the full sample set.
In addition, we performed permutation analysis to estimate the fraction of false positives in our find-
ings. Specifically, we randomly permuted the ages of samples and repeated the test using M8 for 1,000 
times. We counted the number of tests in which more age-associated genes were identified, and removed 
the tissues whose number was larger than 5. It is of note that M8 delivers greater number of aging genes 
than M9, therefore provides an upper bound value of FDR.
To estimate the impact of sample size, we randomly selected samples of sizes 10 to 150 with 10 
additional samples added each time for each tissue and repeated this process 100 times using M8 (see 
Supplementary Fig. S6). As expected, large sample sizes increases the power of identifying age-associated 
genes (e.g., more than 30 fold increase in the number of detected age-associated genes in whole blood 
when sample size increases from 10 to 150).
Synchronization pattern of multi-tissue aging in humans. To study the co-aging of multiple 
tissues, a PCA method was performed to reduce the dimensionality of the gene expression data. We 
compared different tissues based on the first PC of gene expression. The co-aging coefficient of two tis-
sues was defined as the Spearman correlation coefficient between the coordinates of samples on the first 
PC (for the two tissues) (see Fig. 3a).
To estimate the aging deviation of a sample in n tissues, we mapped each sample into an n dimen-
sional Euclidean space with each coordinate being its rank (based on its coordinate on PC1) among the 
overlapping samples in a tissue. Similarly, we also ranked the samples by their chronological age. Let 
(r1, r2,···, rn) be the rank vector of a sample on n tissues and r be its rank on chronological age. We defined 




Visualizing tissue co-aging in 3D space. We choose heart, lung, and blood as an example for vis-
ualizing tissue co-aging in 3D space. After rank deviation was calculated for each sample, we estimated 
the corresponding p-value assuming that the distance has a normal distribution and considered samples 
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with p-values less than 0.05 as outliers. Jmol (http://www.jmol.org/) was used for the visualization (see 
Fig. 3d).
Assembly of disease gene list and disease-aging gene link detection. The disease genes were 
retrieved from two sources: NIH Genome-Wide Association Studies (GWAS) Catalog40 (accessed on Aug 
13, 2014) and OMIM (Online Mendelian Inheritance in Man, accessed on Aug 13, 2014)41. We only 
considered genes in the GWAS Catalog with p-value < 5 × 10−8, a generally accepted threshold for 
genome-wide significance. Clustering and manual curation were used to merge genes in GWAS and 
OMIM (See Supplementary Data S9 and S10). We only considered diseases with at least 5 genes. We then 
performed a Fisher’s exact test between the disease genes and aging genes in each tissue. Aging genes 
with FDR ≤ 0.02 were used for testing age-disease overlap enrichment (p-values less than 0.05 were 
considered significant). In addition, we separated the up- and down-regulated genes with age. To visu-
alize the result, we selected the top 10 most significant diseases in each tissue, which resulted in 55 
unique diseases for up-regulated or 53 for down-regulated aging genes. The normalized − ( )plog10  for 
each disease-tissue pair was plotted in Fig. 4.
Data access. The GTEx genotype and gene expression data were downloaded from dbGap under 
dbGaP Study Accession number phs000424.v3.p1. MuTHER gene expression data was obtained from 
http://www.ebi.ac.uk/arrayexpress/experiments/E-TABM-1140/, accessed on 2-26-2015.
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